Deep Proteomic Insight Across Human Biofluids
Evotec optimized their clinical proteomics platform with Seer technology.
Human biofluids provide a rich source of information that can be used to predict a patient’s disease state and guide drug development or personalized therapies.
In this webinar, we show how the combination of the Proteograph™ Product Suite and high-end mass spectrometry provides unbiased access to thousands of proteins that have not been detectable by conventional clinical proteomics techniques.
For the first time, we present unique insight into Evotec’s benchmark data set on human serum, plasma, cerebrospinal fluid (CSF), urine, and cell secretome!
This webinar is best for:
- Proteomics, mass spectrometry, and multi-omics research professionals.
- Scientists focused on the study of human biofluids.
- General scientific community.
Things you’ll learn about:
- Seer’s multi nanoparticle-based workflow and Proteograph Product Suite.
- Evotec and the company’s clinical proteomics platform and workflow.
- Seer and Evotec’s novel approach for deep, unbiased proteomics.
- Evotec’s human biofluid benchmark study analyzing serum/plasma, cerebrospinal fluid (CSF), urine, and secretome samples using the Proteograph.
- The Proteograph’s workflow performance across different sample types.
Featured Speakers
Carleen Kluger, Ph.D. GL, Clinical Proteomics, Mass Spectrometry, Evotec
Daniel Hornburg, Ph.D. VP, Proteomics, Seer Inc.
Watch Webinar On-Demand
Fill out the form to watch the webinar.